Human cell line HEK293T stably expressing CRISPR Cas9, single clone

The University of Virginia awarded contract A207_PO-0474981 to Genecopoeia Inc. on August 29, 2026, for the procurement of specialized biological research materials. The contract encompasses the delivery of one human cell line HEK293T stably expressing CRISPR Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats–associated protein 9), a single clone variant. The line item was delivered to Rachel Clements at the contracting organization. The contract cumulative value totals $2,186.00, with a unit price of $2,186.00 per cell line delivery.

Genecopoeia Inc. serves as the prime contractor for this procurement, which supports research activities at the University of Virginia in Virginia. The HEK293T cell line with stable CRISPR Cas9 expression represents a standardized research tool commonly utilized in molecular biology and genetic engineering applications. No additional performance period details or annual value information is specified in the contract documentation provided.